PMID: 8590280Aug 31, 1995Paper

Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1

DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes
T NagaseN Nomura

Abstract

In this series of projects regarding the accumulation of sequence information of unidentified human genes, we newly deduced the sequences of 40 full-length cDNA clones of human cell line KG-1, and predicted the coding sequences of the corresponding genes, named KIAA0121 to 0160. The results of a computer search of public databases indicated that the sequences of 13 genes were unrelated to any reported genes, while the remaining 27 genes carried sequences which showed some similarities to known genes. Obvious unique sequences noted were as follows. A stretch of triplet repeats was contained in each of three genes: These were GAG(Glu) in KIAA0122 and KIAA0147, and TCC(Ser) in KIAA0150. A stretch of 10 amino acid-residues was repeated 21 times in KIAA0139, and a homologous sequence of 76-78 nucleotides was found repeated 6 times in the untranslated region of KIAA0125. Northern hybridization analysis demonstrated that 13 genes were expressed in a cell- or tissue-specific manner. Although a vast number of expressed sequence tags (ESTs) have been registered for comprehensive analysis of cDNA clones, our sequence data indicated that their distribution is very unbalanced: e.g. while no EST hit 7 genes, 85 ESTs fell in a single gene.

Citations

Nov 7, 2000·The Journal of Comparative Neurology·A KinoshitaM Kinoshita
Mar 29, 2002·Cell Motility and the Cytoskeleton·Michaella VelichkovaTama Hasson
Oct 30, 2004·Journal of Cellular Biochemistry·Leslie C SutherlandCory D Morin
Feb 1, 1997·Protein Science : a Publication of the Protein Society·C P Ponting
Nov 1, 2003·Biochemical and Biophysical Research Communications·Satoshi HiroseHitoshi Sakano
Feb 5, 2002·Cancer Letters·Zhong you LiHaruhiko Sugimura
Apr 16, 2002·The International Journal of Biochemistry & Cell Biology·Simona ParisIvan de Curtis
Sep 24, 2004·Biochemistry·Gordon D StrachanKelly L Jordan-Sciutto
Aug 23, 2012·Journal of Proteome Research·Lisa Venticinque, Daniel Meruelo
Dec 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·L ZakinP Brulet
Dec 8, 1998·The Journal of Experimental Medicine·F MatsudaT Honjo
Feb 5, 2000·AIDS Research and Human Retroviruses·V Z TarantulW Bodemer
Dec 10, 1999·Molecular Biology of the Cell·J P CabaniolsP A Roche
May 29, 2002·The EMBO Journal·Mathias BellAlbrecht Bindereif
Aug 15, 1998·Nucleic Acids Research·Z ZhangS F Altschul
Jul 5, 2013·BMC Molecular Biology·Khalid Amine TimaniJohnny J He
Oct 22, 2005·International Journal of Medical Sciences·V V NenashevaV Z Tarantul
May 18, 2000·Biochemical and Biophysical Research Communications·H TakatsuK Nakayama
Apr 27, 2001·Biochemical and Biophysical Research Communications·A MethnerJ Lewerenz
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·L Carrel, H F Willard
Jan 1, 2012·ISRN Molecular Biology·Arrigo De Benedetti
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·R T PremontR J Lefkowitz
Jul 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·J RutterS L McKnight

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.